Costa Mesa, California (PRWEB) February 18, 2013
WCCT Global, a contract research organization (CRO) supporting Phase I - IV biopharmaceutical and device development headquartered in Southern California, today welcomes Gary Urban as Executive Director, Corporate Compliance and Quality. As a Contract Research Organization professional for the past 16 years, Gary has held executive-level positions with global responsibility for Quality Management Systems, Clinical and Corporate Operations, and Information Technology. Gary earned a Bachelor of Science in Business Administration with a concentration in international business from Colorado Technical University. Gary is also certified in Good Clinical Practice and Lean Six Sigma Black Belt. When asked how Gary felt to be joining WCCT Global, he replied, “I am extremely excited to have joined this dynamic and growing organization, and look forward to leveraging my background in organizational optimization, leading companies successfully through growth and change, while ensuring the highest levels of quality, efficiency, and client and associate satisfaction.”
This is another great addition to WCCT Global because the service offering that WCCT Global is providing continues to grow which is why WCCT Global is contacted by sponsors all over the world to perform clinical studies in many different therapeutic areas. WCCT Global’s Chief Operating Officer Jon Rojas says, “Gary’s experience in I.T. and quality assurance allows WCCT Global to bring new technology, ensuring quality within our organization which in turn expands the breadth of services that we can offer to our clients.”
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE.
Read the full story at http://www.prweb.com/releases/2013/2/prweb10437942.htm.
Copyright©2012 Vocus, Inc.
All rights reserved